Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

7 results

  1. ... in most clinical settings. A variety of other regimens have been used, but none have increased OS when compared with doxorubicin alone.[ 1 , 2 ] There is some evidence that the addition of ifosfamide (with mesna) to doxorubicin increases response rates and progression-free ...
  2. ... Ryan L, Sulkes A, et al.: Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or ...
  3. ... Miser JS, Kinsella TJ, Triche TJ, et al.: Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other ...
  4. ... Barrett RJ, et al.: Phase II trial of ifosfamide and mesna in leiomyosarcoma of the ... of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced ...
  5. ... 25 ] and perhaps other alkylating agents, such as ifosfamide (although the use of mesna in conjunction with these agents may reduce the ...
  6. ... consists of combination chemotherapy. The most frequently used regimen is CHOP (cyclophosphamide, vincristine, doxorubicin and prednisolone) which although reasonably well tolerated is ...
  7. ... ibritumomab tiuxetan ibrutinib IBS ibuprofen ICD ICE ICE ... alpha-2B iFOBT ifosfamide Ig IGF IGF-1R inhibitor OSI-906 IGFR ...